Control of drug release from capsules using high frequency energy transmission systems

被引:15
作者
Groening, R. [1 ]
Bensmann, H. [1 ]
Mueller, R. S. [1 ]
机构
[1] Univ Munster, Inst Pharmazeut Technol & Biopharm, D-4400 Munster, Germany
关键词
High frequency energy transmission system; Delayed drug release; Pulsed release; Gas generating reactor; Tramadol;
D O I
10.1016/j.ijpharm.2008.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present investigations new drug delivery systems have been developed, which are controlled by a computer and a high frequency energy transmission system. The capsules consist of a drug reservoir, a high frequency receiver, a gas generating section and a piston to pump a drug solution or drug suspension out of the reservoir. Mechanical energy is generated inside the capsule through electrolysis, if a 27 MHz high frequency field is in resonance with the receiver inside the capsule. Two different miniaturised oscillatory circuits were constructed, which act as the receivers in the capsules. Tramadol was used in release experiments as a model drug. Delayed and pulsed release profiles were obtained. A computer-controlled system was constructed, in which the programmed release profiles are compared with the actual release of the drug. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 14 条
[1]  
AHN JM, 1992, ASAIO J, V39, pM208
[2]   Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon [J].
Clear, NJ ;
Milton, A ;
Humphrey, M ;
Henry, BT ;
Wulff, M ;
Nichols, DJ ;
Anziano, RJ ;
Wilding, I .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (04) :375-384
[3]  
FRYER TB, 1978, BIOTELEM PAT MON, V5, P53
[4]  
Gstoettner W, 2000, WIEN KLIN WOCHENSCHR, V112, P464
[5]  
HELMICKI AJ, 1992, ASAIO J, V42, pM624
[6]  
LAUFEN H, 1987, METHODS CLIN PHARM, V7, P76
[7]  
Pavie A, 2003, ARCH MAL COEUR VAISS, V96, P934
[8]   Use of the InteliSite® capsule to study ranitidine absorption from various sites within the human intestinal tract [J].
Pithavala, YK ;
Heizer, WD ;
Parr, AF ;
O'Connor-Semmes, RL ;
Brouwer, KLR .
PHARMACEUTICAL RESEARCH, 1998, 15 (12) :1869-1875
[9]   Neuroelectric mechanisms applied to low frequency electric and magnetic field exposure guidelines - Part I: Sinusoidal waveforms [J].
Reilly, JP .
HEALTH PHYSICS, 2002, 83 (03) :341-355
[10]  
SCHUSTER O, 1987, METHODS CLIN PHARM, V7, P28